Why Speros?
Speros is being built as a convergent campus to facilitate the discovery, development and deployment of next-generation modalities to treat and cure cancer, especially cell therapies and radiopharmaceuticals.
Anchored by Moffitt Cancer Center, the Tampa Bay region’s only NCI-designated cancer center, our investments in clinical and research capabilities, as well as supporting infrastructure, are accelerating the recruitment of top radiopharma talent, including nuclear medicine physicians, radiation oncologists, and RLT-trained clinical staff already on the Speros campus
-
600M
invested in enabling infrastructure to support new companies
-
600,000+
annual visits over the next decade
-
200,000+
patients projected
-
100,000+
patients
-
~30,000
new patients annually
-
1 of 29
academic centers in the U.S. designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence
FORGE
FORGE, the Florida Oncology and Radiopharmaceutical Growth Engine, is a collaborative transforming the Greater Tampa Bay Region into a nationally significant hub for radiopharmaceutical development, advanced manufacturing, and precision oncology workforce training.
Independent economic analysis estimates FORGE could support approximately:
- 2,800 jobs in Pasco County
- 4,000 jobs across the Tampa Bay region
- $1.9 billion in economic impact locally
- $2.6 billion in economic impact regionally
- 396% increase in regional biotechnology workforce
- +650 direct high-paying scientific and technical jobs
Project Partners and Governance
FORGE brings together a strong coalition of public, academic, and private-sector partners, including:
FORGE Incubator: Tampa Bay’s first web lab-capable radiopharmaceutical-ready start up facility serving as the commercialization engine for the coalition.
CORE Program: Florida’s first NRC-compliant nuclear pharmacist training pipeline combining curriculum with internships with Moffitt, RLS Radiopharmacies, and PETNET Solutions to support experiential training.
Integrated Theranostics Center: 26K SF cGMP isotope production facility built with integrated hot cells, Class C quality control labs and cold-chain staging.
IMPACT Program: Expanding radiologic technology training, including launch of Mammography and CT Advanced Technical Certificates.